by John A. Jenkins | Apr 9, 2026 | FDA, FOIA, Litigation, Medical Devices, Short-Selling, Stock Market
How FOIA Requests Signaled Problems With a “Bionic Pancreas” At a federal advisory panel meeting in 2018, a biomedical engineer named Ed Damiano stepped to the microphone – not just as a scientist. “I’m also a father,” he told regulators, describing his son’s...
by John A. Jenkins | Apr 1, 2026 | FDA, FOIA
FOIAengine: Advocates on Both Sides Push FDA for Data as a Senate Investigation Begins Even before Sen. Josh Hawley (R-Mo.) walked into a March 11 news conference to kick off an effort to ban the abortion drug mifepristone as unsafe – and days before he opened an...
by John A. Jenkins | Mar 26, 2026 | FDA, FOIA
FOIAengine: How FOIA Requests Pointed to Problems at Boston Scientific Months before Boston Scientific expanded its urgent warning this month about the risk of sudden death from its Accolade pacemakers, something quieter was happening inside the U.S. Food and Drug...
by John A. Jenkins | Mar 11, 2026 | DOJ, FOIA, Politics, SEC
FOIAengine: How a Grassroots Movement Saw New Evidence of a Conspiracy In December, a retired California Highway Patrol officer named Wilma Stone filed an unusual Freedom of Information Act request with the Securities and Exchange Commission. Stone asked the agency...
by John A. Jenkins | Feb 11, 2026 | FOIA, News Media
FOIAengine: Hundreds of Requests Probing How FDA Weighs Risk and Responds to Warnings A new tranche of just-released Freedom of Information Act requests from news organizations shows how reporters are using the act as an investigative tool to reconstruct internal...
